Primary record
11a,17ss-dihydroxy-17-methyl-Androst-4-en-3-one; 11a-Hydroxy-17-methyltestosterone; 11a-Hydroxy-17a-methyltestosterone; 17a-Methyl-11a17-dihydroxy-4-androsten-3-one; NSC 12433; U 5662; ?4-Androsten-3-one-11a,17ss-diol-17a-methyl;
- 库存
- 3,816 克
- 纯度
- 99.8 %
- CAS
- 1807-02-9
化合物标识与属性
- CAS
- 1807-02-9
- PubChem CID
- 102164
- SMILES
- C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O
- Canonical SMILES
- C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@H](O)C[C@@]2(C)[C@H]1CC[C@]2(C)O
名称与同义词
- UNII-0W51MUL8AL
- 0W51MUL8AL
- RefChem:78021
- 11alpha-Hydroxy-17-methyltestosterone
- AC1L2S9Y
- 11alpha,17beta-Dihydroxy-17-methylandrost-4-en-3-one
- 1807-02-9
- EINECS 217-306-7
- NSC 12433
- SCHEMBL8342173
- C20H30O3
- CHEBI:34138
- NSC-12433
- NSC 3359
- ZINC6067513
- AR-1C0552
- CID102164
- 11|A-hydroxy-17|A-methyltestosterone
- 11alpha-Hydroxy-17alpha-methyltestosterone
- C20-H30-O3
- FH67260
- MSK011007-100A
- 11ALPHA-HYDROXYMETHYLTESTOSTERONE
- 11.ALPHA.-HYDROXY-17-METHYLTESTOSTERONE
- J199.630D
- NS00082458
- C14555
- U-5437
- 11.ALPHA.-HYDROXY-17.ALPHA.-METHYLTESTOSTERONE
- 4-Androsten-17alpha-methyl-11alpha,17beta-diol-3-one
- Androst-4-en-3-one, 11,17-dihydroxy-17-methyl-, (11alpha,17beta)-
- (8S,9S,10R,11R,13S,14S,17S)-11,17-dihydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- Q27115840
- Androst-4-en-3-one, 11,17-dihydroxy-17-methyl-, (11.alpha.,17.beta.)-
- (11a,17b)-11,17-Dihydroxy-17-methylandrost-4-en-3-one
- 11.ALPHA.,17.BETA.-DIHYDROXY-17-METHYLANDROST-4-EN-3-ONE
- 17.ALPHA.-METHYL-11.ALPHA.17-DIHYDROXY-4-ANDROSTEN-3-ONE
- 11,17-DIHYDROXY-17-METHYLANDROST-4-ENE-3-ONE, (11-ALPHA,17-BETA)-
- 17ALPHA-METHYL-11ALPHA17-DIHYDROXY-4-ANDROSTEN-3-ONE
- (11alpha,17beta)-11,17-dihydroxy-17-methylandrost-4-en-3-one (1mg/ml in Acetonitrile)
- 4-Androsten-17alpha-methyl-11alpha,17beta-diol-3-one Solution in Acetonitrile, 100ug/mL
- Androst-4-en-3-one, 11,17-dihydroxy-17-methyl-, (11alpha,17beta)-(9CI)
- (1S,3aS,3bS,9aR,9bS,10R,11aS)-1,10-dihydroxy-1,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
- (8S,10R,11R,13S,17S)-11,17-Dihydroxy-10,13,17-trimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
- (8S,9S,10R,11R,13S,14S,17S)-11,17-dihydroxy-10,13,17-trimethyl-1,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-2H-cyclopenta[a]phenanthren-3(6H)-one
- (8S,9S,10R,13S,14S)-11,17-dihydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- 11a,17ss-dihydroxy-17-methyl-Androst-4-en-3-one; 11a-Hydroxy-17-methyltestosterone; 11a-Hydroxy-17a-methyltestosterone; 17a-Methyl-11a17-dihydroxy-4-androsten-3-one; NSC 12433; U 5662; ?4-Androsten-3-one-11a,17ss-diol-17a-methyl;
- 1841-46-9